(Q37124700)

18 August 2017

Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan (English)

1 reference

18 August 2017

0 references

hepatocellular carcinoma

1 reference

1

Masatoshi Kudo

1 reference

18 August 2017

10

Masatoshi Makuuchi

1 reference

18 August 2017

9

Norihiro Kokudo

1 reference

18 August 2017

4

Yutaka Matsuyama

1 reference

18 August 2017

2

Namiki Izumi

1 reference

18 August 2017

5

Takafumi Ichida

1 reference

18 August 2017

3

Michiie Sakamoto

1 reference

18 August 2017

6

Osamu Nakashima

1 reference

Liver Cancer Study Group of Japan

18 August 2017

series ordinal

11

object named as

Liver Cancer Study Group of Japan

1 reference

18 August 2017

Osamu Matsui

7

1 reference

18 August 2017

Yonson Ku

series ordinal

8

1 reference

18 August 2017

language of work or name

1 reference

10 May 2016

1 reference

18 August 2017

1 reference

18 August 2017

5

1 reference

18 August 2017

3

1 reference

18 August 2017

190-197

1 reference

18 August 2017

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Demonstration of quality of care measurement using the Japanese liver cancer registry

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Sorafenib in advanced hepatocellular carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

14 September 2017

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Epidemiology of hepatocellular carcinoma in Japan

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Surveillance for hepatocellular carcinoma: in whom and how?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version).

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

[Practice guideline for diagnosis and treatment of hepatocellular carcinoma].

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

The management of hepatocellular carcinoma in Asia: a guideline combining quantitative and qualitative evaluation

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960353

Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27493894

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1159/000367775

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

27493894

1 reference